This research service focuses on the U.S. Radiopharmaceutical Agents markets, which is segmented into cardiology diagnostics, other diagnostics, FDG, and therapeutic market segments. The research service covers the markets for these radiopharmaceutical agents over an eleven year period, from 2004 to 2014, with the base year being 2007. The research service provides a comprehensive analysis and forecasts for revenue by segment, demand analysis including data on procedure volumes, procedure types, and installed base, competitive structure and market share analysis, and product analysis. Market drivers, restraints, and challenges have also been identified along with strategic recommendations.